155 results
Page 4 of 8
8-K
EX-10.7
yqp2h7ojeg gytnq
6 Jun 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
0tz 2e79rml
21 Apr 17
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.1
kl95vn2tyeqwpw3gn
13 Mar 17
OncBioMune Acquires Vitel Laboratorios, Gains Two Revenue Generating Drugs, Robust Pipeline and Extensive Distribution Network
12:00am
8-K
EX-10.5
gea wdr4otonee
13 Mar 17
OncBioMune Acquires Vitel Laboratorios, Gains Two Revenue Generating Drugs, Robust Pipeline and Extensive Distribution Network
12:00am
8-K
EX-10.4
2sdcbj
13 Mar 17
OncBioMune Acquires Vitel Laboratorios, Gains Two Revenue Generating Drugs, Robust Pipeline and Extensive Distribution Network
12:00am
8-K
EX-10.3
axkzwhs
13 Mar 17
OncBioMune Acquires Vitel Laboratorios, Gains Two Revenue Generating Drugs, Robust Pipeline and Extensive Distribution Network
12:00am
8-K
EX-10.2
m6qh vupawtfk
13 Mar 17
OncBioMune Acquires Vitel Laboratorios, Gains Two Revenue Generating Drugs, Robust Pipeline and Extensive Distribution Network
12:00am
8-K
EX-10.6
f8s9yz9o2c61m
13 Mar 17
OncBioMune Acquires Vitel Laboratorios, Gains Two Revenue Generating Drugs, Robust Pipeline and Extensive Distribution Network
12:00am
8-K
EX-10.1
7u945bn8k7
28 Nov 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
h6wqt733b7vj
26 Aug 16
Financial Statements and Exhibits
12:00am